Functionalization of electrospun poly(caprolactone) fibers for pH-controlled delivery of doxorubicin hydrochloride

References

• Huang X, Brazel CS. On the importance and mechanisms of burst release in matrix-controlled drug delivery systems. J. Controlled Release. 2001;73:121–136.10.1016/S0168-3659(01)00248-6
   PubMed Web of Science ®Google Scholar
• Griffith L. Polymeric biomaterials. Acta Mater. 2000;48:263–277.10.1016/S1359-6454(99)00299-2
   Web of Science ®Google Scholar
• Cited 2015 Mar 4 http://www.cancer.org/research/cancerfactsstatistics/cancerfactsfigures2015/index
   Google Scholar
• Cited 2015 Sep 2 http://www.cancer.org/treatment/treatmentsandsideeffects/guidetocancerdrugs/doxorubicin
   Google Scholar
• Tacar O, Sriamornsak P, Dass CR. Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems. J. Pharm. Pharmacol. 2013;65:157–170.10.1111/jphp.2013.65.issue-2
   PubMed Web of Science ®Google Scholar
• Kunieda K, Seki T, Nakatani S, et al. Implantation treatment method of slow release anticancer doxorubicin containing hydroxyapatite (DOX-HAP) complex. A basic study of a new treatment for hepatic cancer. Br. J. Cancer. 1993;67:668–673.10.1038/bjc.1993.124
   PubMed Web of Science ®Google Scholar
• Dapas B, Perissin L, Pucillo C, et al. Increase in therapeutic index of doxorubicin and vinblastine by aptameric oligonucleotide in human T lymphoblastic drug-sensitive and multidrug-resistant cells. Antisense Nucleic Acid Drug Dev. 2002;12:247–255.10.1089/108729002320351566
   PubMedGoogle Scholar
• Leonard RCF, Williams S, Tulpule A, et al. Improving the therapeutic index of anthracycline chemotherapy: focus on liposomal doxorubicin (Myocet™). Breast. 2009;18:218–224.10.1016/j.breast.2009.05.004
   PubMed Web of Science ®Google Scholar
• Zocchi E, Tonetti M, Polvani C, et al. Encapsulation of doxorubicin in liver-targeted erythrocytes increases the therapeutic index of the drug in a murine metastatic model. Proc. Nat. Acad. Sci. 1989;86:2040–2044.10.1073/pnas.86.6.2040
   PubMed Web of Science ®Google Scholar
• Wang S, Xu H, Xu J, et al. Sustained liver targeting and improved antiproliferative effect of doxorubicin liposomes modified with galactosylated lipid and PEG-lipid. AAPS Pharm. Sci. Tech. 2010;11:870–877.10.1208/s12249-010-9450-8
   PubMed Web of Science ®Google Scholar
• Dadsetan M, Taylor KE, Yong C, et al. Controlled release of doxorubicin from pH-responsive microgels. Acta Biomater. 2013;9:5438–5446.10.1016/j.actbio.2012.09.019
   PubMed Web of Science ®Google Scholar
• Yao X, Chen L, Chen X, et al. Intercellular pH-responsive histidine modified dextran-g-cholesterol micelle for anticancer drug delivery. Colloids Surf. B. 2014;121:36–43.10.1016/j.colsurfb.2014.05.032
   PubMed Web of Science ®Google Scholar
• Sanson C, Schatz C, Le Meins J, et al. A simple method to achieve high doxorubicin loading in biodegradable polymersomes. J. Controlled Release. 2010;147:428–435.10.1016/j.jconrel.2010.07.123
   PubMed Web of Science ®Google Scholar
• Akbarzadeh A, Zarghami N, Mikaeili H, et al. Synthesis, characterization, and in vitro evaluation of novel polymer-coated magnetic nanoparticles for controlled delivery of doxorubicin. Nanotechnol. Sci. Appl. 2012;5:13–25.
   PubMedGoogle Scholar
• Xu X, Yang L, Xu X, et al. Ultrafine medicated fibers electrospun from W/O emulsions. J. Controlled Release. 2005;108:33–42.10.1016/j.jconrel.2005.07.021
   PubMed Web of Science ®Google Scholar
• Liu S, Zhou G, Liu D, et al. Inhibition of orthotopic secondary hepatic carcinoma in mice by doxorubicin-loaded electrospun polylactide nanofibers. J. Mater. Chem. B. 2013;1:101–109.10.1039/C2TB00121G
   PubMed Web of Science ®Google Scholar
• Zheng F, Wang S, Shen M, et al. Antitumor efficacy of doxorubicin-loaded electrospun nano-hydroxyapatite–poly (lactic-co-glycolic acid) composite nanofibers. Polym. Chem. 2013;4:933–941.10.1039/C2PY20779F
   Web of Science ®Google Scholar
• Ignatova MG, Manolova NE, Toshkova RA, et al. Electrospun nanofibrous mats containing quaternized chitosan and polylactide with in vitro antitumor activity against HeLa cells. Biomacromolecules. 2010;11:1633–1645.10.1021/bm100285n
   PubMed Web of Science ®Google Scholar
• Jiang J, Xie J, Ma B, et al. Mussel-inspired protein-mediated surface functionalization of electrospun nanofibers for pH-responsive drug delivery. Acta Biomater. 2014;10:1324–1332.10.1016/j.actbio.2013.11.012
   PubMed Web of Science ®Google Scholar
• Zeng J, Yang L, Liang Q, et al. Influence of the drug compatibility with polymer solution on the release kinetics of electrospun fiber formulation. J. Controlled Release. 2005;105:43–51.10.1016/j.jconrel.2005.02.024
   PubMed Web of Science ®Google Scholar
• Zamani M, Prabhakaran MP, Ramakrishna S. Advances in drug delivery via electrospun and electrosprayed nanomaterials. Int. J. Nanomed. 2013;8:2997–3017.
   PubMed Web of Science ®Google Scholar
• Yang Y, Li X, Qi M, et al. Release pattern and structural integrity of lysozyme encapsulated in core–sheath structured poly(dl-lactide) ultrafine fibers prepared by emulsion electrospinning. Eur. J. Pharm. Biopharm. 2008;69:106–116.10.1016/j.ejpb.2007.10.016
   PubMed Web of Science ®Google Scholar
• Gil ES, Hudson SM. Stimuli-reponsive polymers and their bioconjugates. Prog. Polym. Sci. 2004;29:1173–1222.10.1016/j.progpolymsci.2004.08.003
   Web of Science ®Google Scholar
• Engin K, Leeper D, Cater J, et al. Extracellular pH distribution in human tumours. Int. J. Hyperthermia. 1995;11:211–216.10.3109/02656739509022457
   PubMed Web of Science ®Google Scholar
• Tannock IF, Rotin D. Acid pH in tumors and its potential for therapeutic exploitation. Cancer Res. 1989;49:4373–4384.
   Google Scholar
• Cited 2015 Sep 2 http://toxnet.nlm.nih.gov/cgi-bin/sis/search2/r?dbs+hsdb:@term+@rn+@rel+23214-92-8
   Google Scholar
• Regis S, Youssefian S, Jassal M, et al. Integrin α5β1-mediated attachment of NIH/3T3 fibroblasts to fibronectin adsorbed onto electrospun polymer scaffolds. Polym. Eng. Sci. 2014;54:2587–2594.10.1002/pen.v54.11
   Web of Science ®Google Scholar
• Jassal M, Bhowmick S, Sengupta S, et al. Hydrolyzed poly (acrylonitrile) electrospun ion-exchange fibers. Environ. Eng. Sci. 2014;31:288–299.10.1089/ees.2013.0436
   PubMed Web of Science ®Google Scholar
• Ho YS, McKay G. Pseudo-second order model for sorption processes. Process Biochem. 1999;34:451–465.10.1016/S0032-9592(98)00112-5
   Web of Science ®Google Scholar
• Zhao J, Lu C, He X, et al. Polyethylenimine-grafted cellulose nanofibril aerogels as versatile vehicles for drug delivery. ACS Appl. Mater. Inter. 2015;7:2607–2615.10.1021/am507601m
   PubMed Web of Science ®Google Scholar
• Yuan X, Xing W, Zhuo S-P, et al. Preparation and application of mesoporous Fe/carbon composites as a drug carrier. Microporous Mesoporous Mater. 2009;117:678–684.10.1016/j.micromeso.2008.07.039
   Web of Science ®Google Scholar
• Jassal M, Sengupta S, Warner SB, et al. Quantitative characterization of functionally modified micron–submicron fibers for tissue regeneration: a review. Text. Res. J. 2013;83:1999–2022.10.1177/0040517513481870
   Web of Science ®Google Scholar
• Ma Z, Kotaki M, Yong T, et al. Surface engineering of electrospun polyethylene terephthalate (PET) nanofibers towards development of a new material for blood vessel engineering. Biomaterials. 2005;26:2527–2536.10.1016/j.biomaterials.2004.07.026
   PubMed Web of Science ®Google Scholar
• Sun H, Mei L, Song C, et al. The in vivo degradation, absorption and excretion of PCL-based implant. Biomaterials. 2006;27:1735–1740.10.1016/j.biomaterials.2005.09.019
   PubMed Web of Science ®Google Scholar
• Hu X, Liu S, Zhou G, et al. Electrospinning of polymeric nanofibers for drug delivery applications. J. Controlled Release. 2014;185:12–21.10.1016/j.jconrel.2014.04.018
   PubMed Web of Science ®Google Scholar
• Szentivanyi A, Chakradeo T, Zernetsch H, et al. Electrospun cellular microenvironments: understanding controlled release and scaffold structure. Adv. Drug Deliv. Rev. 2011;63:209–220.10.1016/j.addr.2010.12.002
   PubMed Web of Science ®Google Scholar
• Srikar R, Yarin AL, Megaridis CM, et al. Desorption-limited mechanism of release from polymer nanofibers. Langmuir. 2008;24:965–974.10.1021/la702449k
   PubMed Web of Science ®Google Scholar
• Costa P, Sousa Lobo JM. Modeling and comparison of dissolution profiles. Eur. J. Pharm. Sci. 2001;13:123–133.10.1016/S0928-0987(01)00095-1
   PubMed Web of Science ®Google Scholar
• Tan JM, Foo JB, Fakurazi S, et al. Release behaviour and toxicity evaluation of levodopa from carboxylated single-walled carbon nanotubes. Beilstein J. Nanotechnol. 2015;6:243–253.10.3762/bjnano.6.23
   PubMed Web of Science ®Google Scholar
• Wang C-J, Chen T-C, Lin J-H, et al. One-step preparation of hydrophilic carbon nanofiber containing magnetic Ni nanoparticles materials and their application in drug delivery. J. Colloid Interface Sci. 2015;440:179–188.10.1016/j.jcis.2014.10.073
   PubMed Web of Science ®Google Scholar
• Rebbaa A, Zheng X, Chu F, et al. The role of histone acetylation versus DNA damage in drug-induced senescence and apoptosis. Cell Death Differ. 2006;13:1960–1967.10.1038/sj.cdd.4401895
   PubMed Web of Science ®Google Scholar
• Liedke PER, Reolon GK, Kilpp B, et al. Systemic administration of doxorubicin impairs aversively motivated memory in rats. Pharmacol. Biochem. Behav. 2009;94:239–243.10.1016/j.pbb.2009.09.001
   PubMed Web of Science ®Google Scholar